Christian Angermayer is a venture capital investor at Presight Capital who focuses specifically on psychedelics, longevity, space, and AI technologies that he believes can extend healthy life and improve happiness. He openly credits his own psychedelic experience as the catalyst for shifting his investment focus toward building an entire psychedelic medicines ecosystem, making him an unusually visible pioneer in establishing medical psychedelics as an institutional asset class. Christian Angermayer is a venture capital investor at Presight Capital who focuses specifically on psychedelics, longevity, space, and AI technologies that he believes can extend healthy life and improve happiness. He openly credits his own psychedelic experience as the catalyst for shifting his investment focus toward building an entire psychedelic medicines ecosystem, making him an unusually visible pioneer in establishing medical psychedelics as an institutional asset class.